Dawn svoronos
WebDec 14, 2024 · --Adverum Biotechnologies, Inc., a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the … WebSee the breakdown of the total annual compensation for Dawn Svoronos for being a board member of PTC THERAPEUTICS INC, as well as other members of the Board of Directors for PTC THERAPEUTICS INC
Dawn svoronos
Did you know?
WebThe Investor Relations website contains information about PTC Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. WebDawn A. Svoronos occupies the position of Chairman at Theratechnologies, Inc. She is also on the board of 6 other companies. Ms. Svoronos previously occupied the position …
WebApr 22, 2024 · Urges Stockholders to Vote the WHITE Proxy Card “FOR” ALL of Adverum’s Three Highly Qualified, Diverse and Independent Directors: Dawn Svoronos, Reed V. Tuckson, M.D. and Thomas Woiwode, Ph ... WebSep 27, 2016 · Svoronos is a pharmaceutical industry executive whose experience includes a 23-year career at Merck & Co. with a focus on commercial operations and marketing, as well as board positions at ...
WebOct 6, 2024 · The estimated Net Worth of Dawn Svoronos is at least $1.09 Million dollars as of 21 June 2024. Ms. Svoronos owns over 1,908 units of Global Blood Therapeutics stock worth over $368,202 and over the last 7 years she sold GBT stock worth over $153,412. In addition, she makes $571,995 as Independent Director at Global Blood Therapeutics. WebMs. Dawn Svoronos (Graham) concluded her twenty-three year commercial career with Merck & Co. Inc as President of Europe & Canada, a region comprised of thirty-seven …
WebDec 13, 2024 · Ms. Svoronos brings to ACELYRIN extensive industry expertise including nearly 25 years of executive commercial leadership experience gained at Merck & Co. …
WebDec 13, 2024 · Ms. Svoronos brings to ACELYRIN extensive industry expertise including nearly 25 years of executive commercial leadership experience gained at Merck & Co. Inc. Prior to her retirement from Merck ... dr mary duck robertshawWebDec 13, 2024 · AaACELYRIN, INC., a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced the appointment of ... dr mary dryden caddWebDawn Svoronos. Ms. Svoronos has served as our Lead Independent Director since June 2024 and as a member of our Board since September 2016. Ms. Svoronos sits on the board of directors of the following publicly traded biopharmaceutical companies: Adverum Biotechnologies, Inc. and Theratechnologies Inc., where she is currently the Chair of its ... dr mary d smithWeb2024. 2024. Board members at this company. Dawn Svoronos. Charles Homcy, M.D. Deval L. Patrick. Expand. As a member of Board of Directors at GLOBAL BLOOD THERAPEUTICS , Dawn Svoronos made $571,995 in total compensation. Of this total $47,500 was received as fees earned or paid in cash, $0 was received as non-stock … dr. mary duck robertshawWebJan 31, 2024 · Dawn Svoronos has served as a member of PTC’s board of directors since June 2016. She has over 30 years of experience in the pharmaceutical industry, … coldfusion convert integer to stringWebDec 13, 2024 · Dec 13, 2024, 07:00 ET. Industry veteran and sought-after Board Director brings more than 30 years of experience as a US and international leader in Biopharma. … coldfusion convert array to stringWebDec 14, 2024 · REDWOOD CITY, Calif., Dec. 14, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targ... coldfusion cleaning header